<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 1.8: Risk Stratification and Establishing the STABLE Baseline</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE/TEAL theme for Diabetes & Blood Sugar */
        .module-header {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #0369a1;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #0369a1;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f9ff;
            border: 2px solid #0ea5e9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #0369a1;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #0ea5e9;
        }

        .term-item .term {
            font-weight: 700;
            color: #0369a1;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #0369a1;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #075985;
            margin: 35px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #0ea5e9;
        }

        .alert-box.info .alert-label {
            color: #0369a1;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #0ea5e9, #0369a1);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #0369a1 0%, #0ea5e9 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            margin-bottom: 8px;
            display: block;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        th {
            background: #f1f5f9;
            color: #0369a1;
            padding: 15px;
            text-align: left;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: #fffcf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #0369a1;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #0369a1;
            margin-top: 15px;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f8fafc;
            padding: 30px;
            border-radius: 14px;
            border: 1px solid #e2e8f0;
            margin-top: 50px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 40px;
        }

        .stat-highlight {
            font-weight: 700;
            color: #0369a1;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
            .lesson-container {
                padding: 20px 15px;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 1: S: Screen & Assess</p>
            <h1 class="lesson-title">Lesson 1.8: Risk Stratification and Establishing the STABLE Baseline</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 8 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Multimodal Integration</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Risk Stratification Framework</a></li>
                <li><a href="#section3"><span class="section-num">3</span>The Red Flag Checklist</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Prioritizing Metabolic Markers</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The STABLE Baseline Blueprint</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Empowering Client Communication</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Synthesize objective blood chemistry, anthropometrics, and subjective symptoms into a single metabolic profile.</li>
                <li>Categorize clients into risk tiers to determine the appropriate intensity of intervention.</li>
                <li>Identify clinical "red flags" that mandate immediate medical referral and suspension of coaching.</li>
                <li>Prioritize metabolic goals using the "Lead vs. Lag" marker framework.</li>
                <li>Communicate complex findings to clients in a way that builds self-efficacy without overstepping scope.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Synthesis of Multimodal Data</h2>
        <p>In the previous seven lessons, we explored individual pieces of the metabolic puzzle: HbA1c, Fasting Insulin, Lipids, Anthropometrics, and CGM data. However, a master Blood Sugar Coach does not look at these in isolation. The <span class="highlight">The S.T.A.B.L.E. Blood Sugar Methodâ„¢</span> requires the integration of multimodal data to see the "metabolic story" the body is telling.</p>
        
        <p>A client may present with a "normal" HbA1c of 5.3%, yet their Fasting Insulin is 18 ÂµIU/mL and their TG/HDL ratio is 4.5. If you only looked at the HbA1c, you would miss the fact that their pancreas is working overtime to maintain that "normal" sugar. This is the difference between a practitioner who manages symptoms and a coach who addresses the <span class="highlight">metabolic root cause</span>.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">82%</span>
                    <span class="stat-label">Predictive Accuracy of TG/HDL for IR</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">10-15yrs</span>
                    <span class="stat-label">Insulin rises before Glucose fails</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">3.1x</span>
                    <span class="stat-label">Risk Increase with HOMA-IR > 2.5</span>
                </div>
            </div>
        </div>

        <h2 id="section2">2. Risk Stratification Framework</h2>
        <p>Risk stratification is the process of determining the severity of a client's metabolic dysfunction. This dictates how aggressively we apply the "Transform Nutrition" and "Activate Movement" modules. We categorize clients into three primary tiers:</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Tier</th>
                        <th>Metabolic Profile</th>
                        <th>Coaching Focus</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Tier 1: Optimized</strong></td>
                        <td>HbA1c < 5.4%, HOMA-IR < 1.5, TG/HDL < 1.5. No visual cues of IR.</td>
                        <td>Longevity, performance, and metabolic flexibility. Fine-tuning.</td>
                    </tr>
                    <tr>
                        <td><strong>Tier 2: Compensated IR</strong></td>
                        <td>HbA1c 5.4-5.6% (Normal), but HOMA-IR > 2.0. High insulin, normal glucose.</td>
                        <td>Aggressive insulin sensitization. Reducing insulin "noise" via nutrition.</td>
                    </tr>
                    <tr>
                        <td><strong>Tier 3: Dysregulated</strong></td>
                        <td>HbA1c 5.7-6.4% (Prediabetes). Elevated glucose and insulin. Visual cues present.</td>
                        <td>Structural lifestyle overhaul. High-frequency monitoring (CGM).</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. The Red Flag Checklist</h2>
        <p>Safety is the cornerstone of professional coaching. As a Diabetes & Blood Sugar Coach, you must be hyper-vigilant for symptoms that suggest a client is moving out of the "lifestyle management" phase and into a "medical emergency" phase.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Warning: Immediate Referral Required</p>
            <p>If a client presents with any of the following, you must halt coaching and direct them to urgent care or their primary physician:</p>
            <ul style="margin-top: 10px;">
                <li><strong>Unexplained Weight Loss:</strong> Losing 10+ lbs rapidly without changes in diet/exercise (potential Type 1 or Type 1.5 LADA onset).</li>
                <li><strong>The "Polys":</strong> Extreme thirst (Polydipsia), extreme hunger (Polyphagia), and frequent urination (Polyuria).</li>
                <li><strong>Fruity Breath:</strong> A sign of Diabetic Ketoacidosis (DKA).</li>
                <li><strong>Visual Disturbances:</strong> Sudden onset of blurred vision or "floaters."</li>
                <li><strong>Numbness/Tingling:</strong> Significant peripheral neuropathy that is progressing rapidly.</li>
            </ul>
        </div>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Skinny Diabetic" Trap</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">M</div>
                    <div class="patient-info">
                        <h4>Marcus, 42</h4>
                        <p>BMI: 23.5 (Normal) | Chief Complaint: Post-meal fatigue and brain fog.</p>
                    </div>
                </div>
                <p>Marcus was dismissed by his doctor because his HbA1c was 5.4%. However, his STABLE assessment revealed:</p>
                <ul>
                    <li><strong>Fasting Insulin:</strong> 22 ÂµIU/mL (High)</li>
                    <li><strong>TG/HDL Ratio:</strong> 4.8 (High)</li>
                    <li><strong>Visual Cues:</strong> Significant skin tags on the neck.</li>
                </ul>
                <p><strong>Outcome:</strong> Marcus was categorized as <span class="highlight">Tier 2: Compensated Insulin Resistance</span>. Despite his normal weight, he had significant visceral fat (TOFI - Thin Outside, Fat Inside). The intervention focused on "The Protein Leverage" (Module 2) rather than calorie restriction.</p>
            </div>
        </div>

        <h2 id="section4">4. Prioritizing Metabolic Markers: SMART Goals</h2>
        <p>Not all markers are created equal. When establishing a baseline, we distinguish between <span class="highlight">Lagging Indicators</span> (HbA1c) and <span class="highlight">Leading Indicators</span> (Fasting Insulin, TG/HDL, CGM Variability).</p>

        <p>A common mistake is setting a goal to "Lower HbA1c by 0.5% in 30 days." Because HbA1c is a 90-day average, this goal is physiologically impossible to measure accurately in a month. Instead, we prioritize markers that respond quickly to lifestyle changes:</p>

        <div class="key-terms-box">
            <p class="box-label">Prioritization Hierarchy</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Priority 1: Glycemic Variability</p>
                    <p class="definition">Reducing the "spikes and crashes" seen on a CGM. This usually improves within 48-72 hours of nutritional changes.</p>
                </div>
                <div class="term-item">
                    <p class="term">Priority 2: Fasting Insulin</p>
                    <p class="definition">Lowering the baseline "pressure" on the pancreas. Measurable change often seen in 4-6 weeks.</p>
                </div>
                <div class="term-item">
                    <p class="term">Priority 3: TG/HDL Ratio</p>
                    <p class="definition">A proxy for liver insulin sensitivity. Typically improves as carbohydrate toxicity is reduced.</p>
                </div>
            </div>
        </div>

        <h2 id="section5">5. Establishing the STABLE Baseline Blueprint</h2>
        <p>The "STABLE Baseline" is the formal documentation of the client's starting point. It serves as the "anchor" for your coaching relationship. A complete baseline blueprint must include:</p>

        <ul class="content-list">
            <li><strong>The Metabolic Compass:</strong> A visual plot of HOMA-IR vs. Waist-to-Height Ratio.</li>
            <li><strong>The Symptom Score:</strong> A quantitative measure of subjective complaints (e.g., a 1-10 scale for energy, cravings, and sleep quality).</li>
            <li><strong>The Nutrient Inventory:</strong> A 3-day snapshot of current macronutrient ratios before any intervention begins.</li>
            <li><strong>The Movement Capacity:</strong> Current step count and resistance training frequency.</li>
        </ul>

        <div class="alert-box info">
            <p class="alert-label">The "Snapshot" Rule</p>
            <p>Never start a "Transform" phase (Module 2) without a finalized baseline. Without a baseline, you cannot prove the efficacy of your coaching, and the client will lose motivation when the initial "water weight" loss slows down.</p>
        </div>

        <h2 id="section6">6. Empowering Client Communication</h2>
        <p>As a coach, your language must be precise. You are not diagnosing a disease; you are <span class="highlight">interpreting metabolic function</span>. Use the "Bridge Technique" to explain results:</p>

        <div class="comparison-grid">
            <div class="comparison-card conventional">
                <p class="card-label">The Diagnostic Approach (Avoid)</p>
                <p class="card-text">"Your labs show you are prediabetic and have high cholesterol. You need to lose weight to fix this."</p>
            </div>
            <div class="comparison-card functional">
                <p class="card-label">The Coaching Approach (Use)</p>
                <p class="card-text">"Your markers suggest your body is currently working very hard to keep your energy stable. We see high insulin levels, which is like a 'metabolic brake' on your fat-burning. Our goal is to release that brake."</p>
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">A client has a normal HbA1c (5.2%) but a Fasting Insulin of 25 ÂµIU/mL. What is their most likely risk tier and why?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    They are Tier 2: Compensated Insulin Resistance. Their body is successfully maintaining normal glucose levels, but at the cost of hyperinsulinemia. This is the "hidden" stage of metabolic dysfunction where coaching is most effective.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">Why is the TG/HDL ratio often prioritized over LDL cholesterol in the STABLE method?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    TG/HDL ratio is a superior proxy for insulin resistance and the presence of small, dense LDL particles. LDL-C alone does not account for metabolic health or insulin sensitivity, whereas a high TG/HDL ratio (>2.0) is strongly correlated with atherogenic dyslipidemia and IR.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Integration is Key:</strong> Never rely on a single marker; look for patterns across labs, symptoms, and visual cues.</li>
                <li><strong>Safety First:</strong> The Red Flag checklist is your non-negotiable protocol for medical referrals.</li>
                <li><strong>Tiered Intervention:</strong> Use risk stratification to determine how "therapeutic" or "preventative" the nutrition plan needs to be.</li>
                <li><strong>Leading vs. Lagging:</strong> Focus initial client goals on insulin and glycemic variability rather than HbA1c.</li>
                <li><strong>Language Matters:</strong> Coach function, don't diagnose disease. Bridge the gap between data and empowerment.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul>
                <li>Unger, R. H., & Cherrington, A. D. (2012). "Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover." Journal of Clinical Investigation.</li>
                <li>Festa, A., et al. (2000). "Chronic inflammation as a predictor of type 2 diabetes: the Insulin Resistance Atherosclerosis Study." JAMA.</li>
                <li>Zimmet, P., et al. (2019). "The metabolic syndrome: a strategic approach to a global epidemic." The Lancet Diabetes & Endocrinology.</li>
                <li>DeFronzo, R. A., et al. (2015). "Type 2 diabetes mellitus." Nature Reviews Disease Primers.</li>
                <li>Kwak, S. H., & Park, K. S. (2016). "Recent progress in genetic and epigenetic research on type 2 diabetes." Experimental & Molecular Medicine.</li>
                <li>American Diabetes Association (2023). "Standards of Care in Diabetesâ€”2023." Diabetes Care.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>